跳至主要内容
临床试验/DRKS00014254
DRKS00014254已完成不适用

A research project for the development of a new in-vitro diagnostic test for tuberculosis. - TID-1

R-Biopharm AG0 个研究点目标入组 547 人开始时间: 2018年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
R-Biopharm AG
入组人数
547

研究概览

简要总结

The goal of developing a test system for the qualitative detection of M. tuberculosis infection was achieved. Based on the evaluation of the collected blood samples, it could be shown that a TB specific release of IP-10 was achieved as soon as the sample comes into contact with the peptides.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • TB-infected participants
  • - Signed informed consent
  • - Age over 18 years
  • - TB-disease confirmed with clinical symptoms and PCR, culture, radiology or microscopy.
  • - Willing and able to donate 50mL blood

排除标准

  • - Any condition or disorder that in the opinion of the investigator will make the participant inappropriate for study participation.

研究者

发起方
R-Biopharm AG

相似试验

A research project for the development of a new... | 临床试验